Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.

Gut - 1 Aug 2005

Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, McKiernan S, Kelleher D

Abstract excerpt

BACKGROUND AND AIMS: Chemokines are small polypeptides, a major function of which is lymphocyte recruitment and trafficking. The aim of this study was to assess the involvement of inherited variations in CCR2, CCR5, and the ligand RANTES in determining disease outcome in hepatitis C virus (HCV) infected individuals. METHODS: A total of 283 women, all exposed to HCV genotype 1b from a single donor, and including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Chemokine CCL5

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Receptors, CCR2

Share to Receptors, CCR5

Share to Receptors, Chemokine

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 15863470
DOI: 10.1136/gut.2004.055699
PMCID: PMC1774905

Genes

CCR2
CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.PMID 15863470Read ↗

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.Semantic proximity Read ↗

Clinical significance of the CCR5delta32 allele in hepatitis C.Semantic proximity Read ↗

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.Semantic proximity Read ↗

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.Semantic proximity Read ↗

Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Semantic proximity Read ↗

The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.Semantic proximity Read ↗

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.Semantic proximity Read ↗

Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study.Semantic proximity Read ↗

CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.